Elena García-Taboada

1.5k total citations
14 papers, 849 citations indexed

About

Elena García-Taboada is a scholar working on Pharmacology, Surgery and Epidemiology. According to data from OpenAlex, Elena García-Taboada has authored 14 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Elena García-Taboada's work include Cannabis and Cannabinoid Research (10 papers), Autophagy in Disease and Therapy (6 papers) and Pancreatic function and diabetes (6 papers). Elena García-Taboada is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Autophagy in Disease and Therapy (6 papers) and Pancreatic function and diabetes (6 papers). Elena García-Taboada collaborates with scholars based in Spain, Austria and Germany. Elena García-Taboada's co-authors include Manuel Guzmán, Mar Lorente, Guillermo Velasco, Sofía Torres, Sonia Hernández‐Tiedra, María Salazar‐Roa, Fátima Rodríguez-Fornés, Juan A. Barcia, Israel López-Valero and Juan Manuel Sepúlveda-Sánchez and has published in prestigious journals such as PLoS ONE, Development and Cell Death and Differentiation.

In The Last Decade

Elena García-Taboada

14 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena García-Taboada Spain 13 571 206 204 186 154 14 849
Concepción Villanueva Spain 8 760 1.3× 280 1.4× 318 1.6× 132 0.7× 215 1.4× 10 1.1k
Maxx P. Horowitz United States 6 268 0.5× 188 0.9× 223 1.1× 98 0.5× 94 0.6× 6 748
David Dávila Spain 13 209 0.4× 145 0.7× 383 1.9× 62 0.3× 94 0.6× 19 804
Sonia Hernández‐Tiedra Spain 15 816 1.4× 276 1.3× 520 2.5× 237 1.3× 265 1.7× 15 1.6k
Clara Andradas Spain 13 678 1.2× 273 1.3× 324 1.6× 167 0.9× 224 1.5× 16 972
Aoife Gowran Ireland 16 373 0.7× 212 1.0× 191 0.9× 67 0.4× 94 0.6× 20 682
Arash Pakdel United States 4 387 0.7× 112 0.5× 114 0.6× 132 0.7× 141 0.9× 4 513
Juanita Allison United States 5 325 0.6× 99 0.5× 113 0.6× 113 0.6× 127 0.8× 5 493
Alessandra Spagnolo United States 11 277 0.5× 141 0.7× 378 1.9× 25 0.1× 52 0.3× 12 795
Yoon‐Seong Kim United States 16 105 0.2× 294 1.4× 362 1.8× 35 0.2× 39 0.3× 28 1.0k

Countries citing papers authored by Elena García-Taboada

Since Specialization
Citations

This map shows the geographic impact of Elena García-Taboada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena García-Taboada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena García-Taboada more than expected).

Fields of papers citing papers by Elena García-Taboada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena García-Taboada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena García-Taboada. The network helps show where Elena García-Taboada may publish in the future.

Co-authorship network of co-authors of Elena García-Taboada

This figure shows the co-authorship network connecting the top 25 collaborators of Elena García-Taboada. A scholar is included among the top collaborators of Elena García-Taboada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena García-Taboada. Elena García-Taboada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Castillo‐Lluva, Sonia, Nélida Salvador, Adrián Blanco‐Gómez, et al.. (2021). The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. Cancers. 13(21). 5307–5307. 10 indexed citations
2.
Martín, Ricardo, Daniel García-Rincón, Elena García-Taboada, et al.. (2020). Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors. Development. 147(24). 14 indexed citations
3.
López-Valero, Israel, David Dávila, Nélida Salvador, et al.. (2020). Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells. Theranostics. 10(11). 5120–5136. 27 indexed citations
4.
Bajo‐Grañeras, Raquel, Debora Zian, G Grabner, et al.. (2019). Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons. Neuropharmacology. 150. 134–144. 20 indexed citations
5.
Palomares, Belén, Raquel Bajo‐Grañeras, Carmen Navarrete, et al.. (2019). Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration. Translational Neurodegeneration. 8(1). 9–9. 28 indexed citations
6.
Blasco-Benito, Sandra, Clara Andradas, Elena García-Taboada, et al.. (2018). Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochemical Pharmacology. 157. 285–293. 129 indexed citations
7.
López-Valero, Israel, Sofía Torres, María Salazar‐Roa, et al.. (2018). Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma. Biochemical Pharmacology. 157. 275–284. 52 indexed citations
8.
López-Valero, Israel, Cristina Sáiz-Ladera, Sofía Torres, et al.. (2018). Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide. Biochemical Pharmacology. 157. 266–274. 86 indexed citations
9.
Chiarlone, Anna, Christine Börner, Laura García‐Bermejo, et al.. (2016). MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling. Neuropharmacology. 108. 345–352. 24 indexed citations
10.
Salazar‐Roa, María, Mar Lorente, Elena García-Taboada, et al.. (2013). The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(10). 1573–1578. 41 indexed citations
11.
Lorente, Mar, María Esther Gil-Alegre, Sofía Torres, et al.. (2013). Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme. PLoS ONE. 8(1). e54795–e54795. 86 indexed citations
12.
Torres, Sofía, Mar Lorente, Fátima Rodríguez-Fornés, et al.. (2011). A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma. Molecular Cancer Therapeutics. 10(1). 90–103. 234 indexed citations
13.
Lorente, Mar, Sofía Torres, María Salazar‐Roa, et al.. (2011). Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death. Autophagy. 7(9). 1071–1073. 24 indexed citations
14.
Lorente, Mar, Sofía Torres, María Salazar‐Roa, et al.. (2011). Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death and Differentiation. 18(6). 959–973. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026